Number of individuals: 120
Significantly mutated genes (q≤0.1) | 193 |
Mutations seen in COSMIC | 0 |
Significantly mutated genes on COSMIC territory | 0 |
Genes with clustered mutations (≤3 aa apart) | 1 |
Significantly mutated genesets | 107 |
. . . . . . . . . (excluding sig.mutated genes) | 33 |
Read 122 MAFs of type "Broad"
Total number of mutations in input MAFs: 36215
After removing 3656 noncoding mutations: 32559
After collapsing adjacent/redundant mutations: 32554
Please see MutSigPreprocess "stdout.txt" for full details.
Number of mutations before filtering: 32554
After removing 56 mutations outside gene set: 32498
After removing 9237 mutations outside category set: 23261
After removing 16119 "impossible" mutations in
gene-patient-category bins of zero coverage: 7142
Please see MutSigRun "stdout.txt" for full details.
Final set of mutations used in analysis
type | count |
---|---|
De_novo_Start_InFrame | 3 |
De_novo_Start_OutOfFrame | 14 |
Missense_Mutation | 4957 |
Nonsense_Mutation | 362 |
Read-through | 6 |
Splice_Site_DNP | 8 |
Splice_Site_SNP | 170 |
Start_Codon_DNP | 1 |
Synonymous | 1621 |
Total | 7142 |
category | n | N | rate | rate_per_mb | relative_rate |
---|---|---|---|---|---|
A->T | 1368 | 43,342,806 | 0.000032 | 31.6 | 0.54 |
C->(A/T) | 2075 | 50,410,660 | 0.000041 | 41.2 | 0.70 |
A->(C/G) | 1119 | 43,342,806 | 0.000026 | 25.8 | 0.44 |
C->G | 396 | 50,410,660 | 7.86e-06 | 7.86 | 0.13 |
indel+null | 563 | 93,753,466 | 6.01e-06 | 6.01 | 0.10 |
Total | 5521 | 93,753,466 | 0.000059 | 58.9 | 1.00 |
rank | gene | description | N | n | npat | nsite | nsil | n1 | n2 | n3 | n4 | n5 | p | q |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | USH2A | Usher syndrome 2A (autosomal recessive, mild) | 120 | 13 | 13 | 13 | 3 | 7 | 0 | 5 | 0 | 1 | <1.00e-11 | <9.93e-09 |
2 | ADAMTS12 | ADAM metallopeptidase with thrombospondin type 1 motif, 12 | 1200 | 17 | 16 | 17 | 3 | 4 | 10 | 1 | 0 | 2 | <1.00e-11 | <9.93e-09 |
3 | SLIT3 | slit homolog 3 (Drosophila) | 480 | 6 | 6 | 6 | 10 | 2 | 2 | 0 | 1 | 1 | <1.00e-11 | <9.93e-09 |
4 | FRAS1 | Fraser syndrome 1 | 1200 | 12 | 10 | 12 | 1 | 6 | 1 | 3 | 1 | 1 | <1.00e-11 | <9.93e-09 |
5 | LRP1B | low density lipoprotein-related protein 1B (deleted in tumors) | 14760 | 45 | 31 | 45 | 8 | 14 | 16 | 10 | 0 | 5 | <1.00e-11 | <9.93e-09 |
6 | PTPRD | protein tyrosine phosphatase, receptor type, D | 6960 | 17 | 14 | 17 | 4 | 4 | 8 | 1 | 1 | 3 | <1.00e-11 | <9.93e-09 |
7 | SVEP1 | sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1 | 3720 | 8 | 8 | 8 | 2 | 3 | 1 | 1 | 0 | 3 | <1.00e-11 | <9.93e-09 |
8 | GPR112 | G protein-coupled receptor 112 | 8520 | 17 | 16 | 17 | 6 | 4 | 5 | 4 | 2 | 2 | <1.00e-11 | <9.93e-09 |
9 | CSMD1 | CUB and Sushi multiple domains 1 | 12592 | 24 | 19 | 24 | 11 | 5 | 13 | 3 | 0 | 3 | <1.00e-11 | <9.93e-09 |
10 | NOTCH4 | Notch homolog 4 (Drosophila) | 5396 | 10 | 9 | 10 | 1 | 2 | 6 | 2 | 0 | 0 | <1.00e-11 | <9.93e-09 |
11 | ABCB5 | ATP-binding cassette, sub-family B (MDR/TAP), member 5 | 6722 | 11 | 11 | 11 | 3 | 3 | 3 | 3 | 0 | 2 | <1.00e-11 | <9.93e-09 |
12 | CSMD3 | CUB and Sushi multiple domains 3 | 25745 | 39 | 25 | 38 | 11 | 16 | 9 | 9 | 1 | 4 | <1.00e-11 | <9.93e-09 |
13 | LAMA2 | laminin, alpha 2 (merosin, congenital muscular dystrophy) | 10440 | 15 | 14 | 15 | 6 | 8 | 3 | 3 | 0 | 1 | <1.00e-11 | <9.93e-09 |
14 | PAPPA2 | pappalysin 2 | 10680 | 12 | 10 | 12 | 3 | 4 | 5 | 3 | 0 | 0 | <1.00e-11 | <9.93e-09 |
15 | RYR3 | ryanodine receptor 3 | 14280 | 15 | 14 | 15 | 6 | 4 | 6 | 4 | 0 | 1 | <1.00e-11 | <9.93e-09 |
16 | KEAP1 | kelch-like ECH-associated protein 1 | 18652 | 18 | 18 | 17 | 0 | 1 | 13 | 1 | 1 | 2 | <1.00e-11 | <9.93e-09 |
17 | RYR2 | ryanodine receptor 2 (cardiac) | 67454 | 44 | 36 | 44 | 11 | 10 | 16 | 12 | 2 | 4 | <1.00e-11 | <9.93e-09 |
18 | MUC16 | mucin 16, cell surface associated | 153487 | 54 | 42 | 53 | 12 | 10 | 25 | 10 | 4 | 5 | <1.00e-11 | <9.93e-09 |
19 | TTN | titin | 299417 | 83 | 42 | 83 | 23 | 27 | 23 | 21 | 7 | 5 | <1.00e-11 | <9.93e-09 |
20 | PCDH15 | protocadherin 15 | 23760 | 15 | 13 | 15 | 7 | 6 | 3 | 1 | 2 | 3 | 1.19e-11 | 1.12e-08 |
21 | CACNA1E | calcium channel, voltage-dependent, R type, alpha 1E subunit | 40579 | 19 | 16 | 19 | 4 | 5 | 5 | 6 | 1 | 2 | 3.31e-11 | 2.97e-08 |
22 | FLT4 | fms-related tyrosine kinase 4 | 454 | 5 | 5 | 5 | 0 | 1 | 1 | 2 | 1 | 0 | 5.48e-11 | 4.70e-08 |
23 | SPTBN4 | spectrin, beta, non-erythrocytic 4 | 129 | 4 | 4 | 4 | 1 | 3 | 0 | 0 | 0 | 1 | 7.03e-11 | 5.77e-08 |
24 | VWF | von Willebrand factor | 1469 | 6 | 6 | 6 | 2 | 0 | 3 | 1 | 2 | 0 | 8.09e-11 | 6.36e-08 |
25 | DMD | dystrophin (muscular dystrophy, Duchenne and Becker types) | 20160 | 12 | 9 | 12 | 4 | 3 | 6 | 0 | 2 | 1 | 7.16e-10 | 5.40e-07 |
26 | SDK1 | sidekick homolog 1, cell adhesion molecule (chicken) | 1753 | 6 | 5 | 6 | 4 | 0 | 5 | 1 | 0 | 0 | 8.93e-10 | 6.48e-07 |
27 | STXBP5L | syntaxin binding protein 5-like | 5040 | 8 | 8 | 8 | 1 | 3 | 2 | 2 | 1 | 0 | 1.78e-09 | 1.24e-06 |
28 | PTPRB | protein tyrosine phosphatase, receptor type, B | 5604 | 8 | 8 | 8 | 2 | 2 | 3 | 2 | 0 | 1 | 6.09e-09 | 4.08e-06 |
29 | BIRC6 | baculoviral IAP repeat-containing 6 (apollon) | 15663 | 11 | 10 | 11 | 0 | 4 | 6 | 1 | 0 | 0 | 6.28e-09 | 4.08e-06 |
30 | MYH13 | myosin, heavy chain 13, skeletal muscle | 5400 | 7 | 7 | 7 | 5 | 4 | 0 | 2 | 1 | 0 | 6.49e-09 | 4.08e-06 |
Notes
N = number of sequenced bases in this gene across the individual set
n = number of (nonsilent) mutations in this gene across the individual set
npat = number of patients (individuals) with at least one nonsilent mutation
nsite = number of unique sites having a nonsilent mutation
nsil = number of silent mutations in this gene across the individual set
n1 = number of nonsilent mutations of type "A->T"
n2 = number of nonsilent mutations of type "C->(A/T)"
n3 = number of nonsilent mutations of type "A->(C/G)"
n4 = number of nonsilent mutations of type "C->G"
n5 = number of nonsilent mutations of type "indel+null"
null = mutation category that includes nonsense, frameshift, splice-site mutations
p_classic = p-value for the observed amount of nonsilent mutations being elevated in this gene
p_ns_s = p-value for the observed nonsilent/silent ratio being elevated in this gene
p = p-value (overall)
q = q-value, False Discovery Rate (Benjamini-Hochberg procedure)
Two distinct analyses are reported using the COSMIC database:
(COS1) COSMIC used as a filter to increase power by restricting the territory of each gene
(COS2) COSMIC used as a prior for the importance of a gene
rank | gene | description | n | cos | n_cos | N_cos | cos_ev | p | q |
---|
Notes
n = number of mutations in this gene in the individual set
cos = number of unique mutated sites in this gene in COSMIC
n_cos = overlap between n and cos
N_cos = number of individuals × cos
cos_ev = total evidence: number of reports in COSMIC for mutations seen in this gene
p = p-value for seeing the observed amount of overlap in this gene
q = q-value, False Discovery Rate (Benjamini-Hochberg procedure)
rank | gene | description | n | cos | n_cos | cos_ev |
---|
Notes
n = number of mutations in this gene in the individual set
cos = number of unique mutated sites in this gene in COSMIC
n_cos = overlap between n and cos
cos_ev = total evidence: number of reports in COSMIC for mutations seen in this gene
gene | patient | chr | start | end | type | n_cos |
---|
rank | gene | desc | n | mindist | npairs3 | npairs12 |
---|---|---|---|---|---|---|
1 | MUC2 | mucin 2, oligomeric mucus/gel-forming | 5 | 2 | 1 | 1 |
2 | GRIN2B | glutamate receptor, ionotropic, N-methyl D-aspartate 2B | 8 | 9 | 0 | 1 |
3 | PKHD1L1 | polycystic kidney and hepatic disease 1 (autosomal recessive)-like 1 | 19 | 116 | 0 | 0 |
4 | MXRA5 | matrix-remodelling associated 5 | 9 | 716 | 0 | 0 |
5 | SH3TC2 | SH3 domain and tetratricopeptide repeats 2 | 5 | 913 | 0 | 0 |
6 | MDN1 | MDN1, midasin homolog (yeast) | 4 | 927 | 0 | 0 |
7 | PDCD11 | programmed cell death 11 | 4 | 1401 | 0 | 0 |
8 | GPR98 | G protein-coupled receptor 98 | 9 | 1445 | 0 | 0 |
9 | A2ML1 | alpha-2-macroglobulin-like 1 | 3 | Inf | 0 | 0 |
10 | AAK1 | AP2 associated kinase 1 | 4 | Inf | 0 | 0 |
11 | AARS2 | alanyl-tRNA synthetase 2, mitochondrial (putative) | 2 | Inf | 0 | 0 |
12 | ABCA10 | ATP-binding cassette, sub-family A (ABC1), member 10 | 4 | Inf | 0 | 0 |
13 | ABCA13 | ATP-binding cassette, sub-family A (ABC1), member 13 | 14 | Inf | 0 | 0 |
14 | ABCA3 | ATP-binding cassette, sub-family A (ABC1), member 3 | 4 | Inf | 0 | 0 |
15 | ABCA4 | ATP-binding cassette, sub-family A (ABC1), member 4 | 3 | Inf | 0 | 0 |
16 | ABCA6 | ATP-binding cassette, sub-family A (ABC1), member 6 | 3 | Inf | 0 | 0 |
17 | ABCA7 | ATP-binding cassette, sub-family A (ABC1), member 7 | 2 | Inf | 0 | 0 |
18 | ABCB1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 | 3 | Inf | 0 | 0 |
19 | ABCB5 | ATP-binding cassette, sub-family B (MDR/TAP), member 5 | 11 | Inf | 0 | 0 |
20 | ABCC12 | ATP-binding cassette, sub-family C (CFTR/MRP), member 12 | 5 | Inf | 0 | 0 |
21 | ABCC3 | ATP-binding cassette, sub-family C (CFTR/MRP), member 3 | 3 | Inf | 0 | 0 |
22 | ABCC5 | ATP-binding cassette, sub-family C (CFTR/MRP), member 5 | 2 | Inf | 0 | 0 |
23 | ABCC8 | ATP-binding cassette, sub-family C (CFTR/MRP), member 8 | 5 | Inf | 0 | 0 |
24 | ABCC9 | ATP-binding cassette, sub-family C (CFTR/MRP), member 9 | 5 | Inf | 0 | 0 |
25 | ABCG4 | ATP-binding cassette, sub-family G (WHITE), member 4 | 2 | Inf | 0 | 0 |
26 | ABCG5 | ATP-binding cassette, sub-family G (WHITE), member 5 (sterolin 1) | 2 | Inf | 0 | 0 |
27 | ABLIM3 | actin binding LIM protein family, member 3 | 3 | Inf | 0 | 0 |
28 | ACACA | acetyl-Coenzyme A carboxylase alpha | 2 | Inf | 0 | 0 |
29 | ACACB | acetyl-Coenzyme A carboxylase beta | 4 | Inf | 0 | 0 |
30 | ACCN2 | amiloride-sensitive cation channel 2, neuronal | 2 | Inf | 0 | 0 |
Notes
n = number of mutations in this gene in the individual set
mindist = distance (in aa) between closest pair of mutations in this gene
npairs3 = how many pairs of mutations are within 3 aa of each other
npairs12 = how many pairs of mutations are within 12 aa of each other
rank | geneset | description | N_genes | mut_tally | N | n | npat | nsite | nsil | n1 | n2 | n3 | n4 | n5 | p | q |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | ARENRF2PATHWAY | Nrf1 and nrf2 are transcription factors that bind to antioxidant response elements (AREs), promoters of genes involved in oxidative damage control. | 13 | CREB1(1), KEAP1(18), PRKCA(2) | 43641 | 21 | 20 | 20 | 1 | 3 | 13 | 1 | 2 | 2 | <1.00e-11 | <6.21e-10 |
2 | NO1PATHWAY | Shear stress in endothelial cells increases cytoplasmic calcium, which activates nitric oxide synthase III to release NO, which in turn regulates cardiac contractions. | 28 | CHRNA1(3), FLT4(5), NOS3(1), RYR2(44), SLC7A1(1) | 239584 | 54 | 38 | 54 | 11 | 13 | 17 | 14 | 5 | 5 | <1.00e-11 | <6.21e-10 |
3 | HSA04720_LONG_TERM_ POTENTIATION | Genes involved in long-term potentiation | 67 | ADCY8(7), ARAF(1), BRAF(4), CACNA1C(8), CAMK2A(1), CAMK2B(3), CAMK2D(1), CAMK4(3), CREBBP(2), GRIA1(3), GRIN2B(8), GRM1(8), ITPR1(2), ITPR2(6), ITPR3(4), KRAS(5), PLCB1(5), PLCB4(3), PPP3CC(1), PRKCA(2), RPS6KA2(1) | 401402 | 78 | 50 | 75 | 25 | 25 | 24 | 15 | 3 | 11 | <1.00e-11 | <6.21e-10 |
4 | STRIATED_MUSCLE_ CONTRACTION | 37 | ACTN3(2), DMD(12), MYBPC2(1), MYBPC3(3), MYH6(7), MYH7(5), MYH8(10), MYOM1(2), NEB(10), TPM2(1), TPM4(1), TTN(83) | 734050 | 137 | 66 | 137 | 42 | 37 | 49 | 28 | 11 | 12 | <1.00e-11 | <6.21e-10 | |
5 | HSA04020_CALCIUM_ SIGNALING_PATHWAY | Genes involved in calcium signaling pathway | 169 | ADCY2(4), ADCY3(1), ADCY4(1), ADCY8(7), ATP2A3(1), ATP2B1(1), ATP2B2(4), ATP2B4(1), CACNA1A(1), CACNA1C(8), CACNA1D(6), CACNA1E(19), CACNA1F(2), CACNA1G(4), CACNA1H(1), CACNA1I(1), CAMK2A(1), CAMK2B(3), CAMK2D(1), CAMK4(3), EGFR(7), GNA11(1), GNAS(3), GRM1(8), ITPR1(2), ITPR2(6), ITPR3(4), MYLK(4), NOS3(1), PDE1A(1), PDE1B(1), PDGFRB(3), PLCB1(5), PLCB4(3), PLCD1(1), PLCD4(2), PLCE1(2), PPP3CC(1), PRKCA(2), PTK2B(2), RYR1(17), RYR2(44), RYR3(15), SLC8A2(1), SLC8A3(4) | 1446030 | 210 | 81 | 208 | 66 | 52 | 72 | 52 | 10 | 24 | <1.00e-11 | <6.21e-10 |
6 | HSA04912_GNRH_SIGNALING_ PATHWAY | Genes involved in GnRH signaling pathway | 95 | ADCY2(4), ADCY3(1), ADCY4(1), ADCY5(4), ADCY8(7), CACNA1C(8), CACNA1D(6), CACNA1F(2), CAMK2A(1), CAMK2B(3), CAMK2D(1), EGFR(7), GNA11(1), GNAS(3), ITPR1(2), ITPR2(6), ITPR3(4), KRAS(5), MAP2K4(1), MAP2K6(1), PLA2G4A(3), PLCB1(5), PLCB4(3), PRKCA(2), PTK2B(2), SOS1(3) | 606893 | 86 | 53 | 81 | 34 | 20 | 23 | 22 | 6 | 15 | <1.00e-11 | <6.21e-10 |
7 | CALCIUM_REGULATION_ IN_CARDIAC_CELLS | 139 | ADCY2(4), ADCY3(1), ADCY4(1), ADCY5(4), ADCY8(7), ATP2A3(1), ATP2B1(1), ATP2B2(4), CACNA1A(1), CACNA1C(8), CACNA1D(6), CACNA1E(19), CAMK2A(1), CAMK2B(3), CAMK2D(1), CAMK4(3), GJB1(1), GNA11(1), GRK4(2), GRK6(1), ITPR1(2), ITPR2(6), ITPR3(4), PRKCA(2), PRKCE(1), RYR1(17), RYR2(44), RYR3(15), SLC8A3(4) | 1280902 | 165 | 70 | 165 | 58 | 38 | 58 | 41 | 7 | 21 | <1.00e-11 | <6.21e-10 | |
8 | HSA04512_ECM_RECEPTOR_ INTERACTION | Genes involved in ECM-receptor interaction | 87 | AGRN(1), CD36(1), COL11A2(2), COL4A1(2), COL4A4(5), COL4A6(8), COL5A3(5), FNDC3A(2), GP1BA(1), GP5(1), HSPG2(5), ITGA1(1), ITGA11(2), ITGA2(3), ITGA5(1), ITGA7(1), ITGA8(6), ITGB4(1), LAMA1(11), LAMA2(15), LAMA3(5), LAMA5(3), LAMB1(4), LAMB2(8), LAMB3(3), LAMB4(8), LAMC3(3), RELN(16), TNC(12), TNXB(5), VWF(6) | 1203307 | 147 | 58 | 147 | 43 | 32 | 72 | 17 | 12 | 14 | <1.00e-11 | <6.21e-10 |
9 | SMOOTH_MUSCLE_CONTRACTION | 138 | ADCY2(4), ADCY3(1), ADCY4(1), ADCY5(4), ADCY8(7), ATP2A3(1), CAMK2A(1), CAMK2B(3), CAMK2D(1), CNN1(1), GRK4(2), GRK6(1), ITPR1(2), ITPR2(6), ITPR3(4), NOS3(1), PLCD1(1), PRKCA(2), PRKCE(1), RYR1(17), RYR2(44), RYR3(15), TNXB(5) | 1026257 | 125 | 62 | 125 | 46 | 28 | 45 | 26 | 9 | 17 | <1.00e-11 | <6.21e-10 | |
10 | HSA04540_GAP_JUNCTION | Genes involved in gap junction | 92 | ADCY2(4), ADCY3(1), ADCY4(1), ADCY5(4), ADCY8(7), EGFR(7), GNA11(1), GNAS(3), GRM1(8), GUCY2C(3), ITPR1(2), ITPR2(6), ITPR3(4), KRAS(5), PDGFRB(3), PLCB1(5), PLCB4(3), PRKCA(2), SOS1(3), TUBA4A(1), TUBB4(1) | 536396 | 74 | 49 | 69 | 28 | 19 | 16 | 18 | 7 | 14 | 1.11e-11 | 6.21e-10 |
Notes: (Please see notes under significantly mutated gene table)
rank | geneset | description | N_genes | mut_tally | N | n | npat | nsite | nsil | n1 | n2 | n3 | n4 | n5 | p | q |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | HSA02010_ABC_TRANSPORTERS_ GENERAL | Genes involved in ABC transporters - general | 42 | ABCA13(14), ABCA3(4), ABCA4(3), ABCA6(3), ABCA7(2), ABCB1(3), ABCC1(1), ABCC10(1), ABCC12(5), ABCC2(1), ABCC3(3), ABCC5(2), ABCC8(5), ABCC9(5), ABCG4(2), ABCG5(2), ABCG8(1), TAP2(1) | 519552 | 58 | 41 | 58 | 12 | 18 | 18 | 11 | 4 | 7 | 0.000080 | 0.046 |
2 | MONOCYTEPATHWAY | Monocytes are a class of immune phagocytes that can develop into macrophages and express LFA-1, CD44, and other surface signaling proteins. | 10 | ITGAL(6), ITGAM(3), SELE(3) | 64350 | 12 | 9 | 12 | 3 | 5 | 2 | 1 | 2 | 2 | 0.00022 | 0.046 |
3 | NEUTROPHILPATHWAY | Neutrophils are phagocytotic leukocytes that destroy foreign cells with reactive oxygen species or enzymatic digestion and express CD11 and CD18. | 8 | ITGAL(6), ITGAM(3), SELE(3) | 64350 | 12 | 9 | 12 | 3 | 5 | 2 | 1 | 2 | 2 | 0.00022 | 0.046 |
4 | LAIRPATHWAY | The local acute inflammatory response is mediated by activated macrophages and mast cells or by complement activation. | 15 | C3(2), C6(2), C7(3), ITGAL(6) | 64791 | 13 | 12 | 13 | 3 | 4 | 5 | 1 | 2 | 1 | 0.00035 | 0.048 |
5 | HSA04670_LEUKOCYTE_ TRANSENDOTHELIAL_ MIGRATION | Genes involved in Leukocyte transendothelial migration | 110 | ACTN3(2), CDH5(1), CTNND1(3), CYBB(1), GRLF1(3), ITGAL(6), ITGAM(3), MYL7(1), PIK3R5(2), PRKCA(2), PTK2(2), PTK2B(2), RHOH(2) | 290756 | 30 | 23 | 30 | 10 | 12 | 10 | 2 | 5 | 1 | 0.00039 | 0.048 |
6 | HSA00680_METHANE_ METABOLISM | Genes involved in methane metabolism | 10 | TPO(6) | 22127 | 6 | 6 | 6 | 2 | 0 | 4 | 0 | 2 | 0 | 0.0011 | 0.074 |
7 | HSA00940_PHENYLPROPANOID_ BIOSYNTHESIS | Genes involved in phenylpropanoid biosynthesis | 7 | TPO(6) | 22127 | 6 | 6 | 6 | 2 | 0 | 4 | 0 | 2 | 0 | 0.0011 | 0.074 |
8 | BLYMPHOCYTEPATHWAY | B cells express the major histocompatibility complex (class II MHC), immunoglobulins, adhesion proteins, and other factors on their cell surface. | 10 | CR1(3), ITGAL(6), PTPRC(6) | 90809 | 15 | 14 | 15 | 1 | 6 | 4 | 2 | 1 | 2 | 0.0011 | 0.074 |
9 | GPCRDB_CLASS_C_METABOTROPIC_ GLUTAMATE_PHEROMONE | 12 | CASR(4), GRM2(2) | 17756 | 6 | 6 | 6 | 0 | 3 | 2 | 1 | 0 | 0 | 0.0012 | 0.074 | |
10 | AGPCRPATHWAY | G-protein coupled receptors (GPCRs) transduce extracellular signals across the plasma membrane; attenuation occurs by signal molecule degradation or receptor-mediated endocytosis. | 11 | GNAS(3), PRKCA(2) | 17733 | 5 | 5 | 5 | 3 | 3 | 0 | 2 | 0 | 0 | 0.0013 | 0.074 |
Notes: (Please see notes under significantly mutated gene table)